Boston makes strides with carotid stent study:
This article was originally published in Clinica
Executive Summary
Boston Scientific has completed the enrolment phase of a clinical trial to assess stenting together with embolic protection in the treatment of carotid artery disease. The single-arm study, called BEACH, is a prospective, non-randomised trial enrolling 747 patients at 47 sites across the US. It is testing Boston's FilterWire EZ embolic protection system and its carotid Wallstent monorail endoprosthesis in patients who are at high risk for traditional surgery - ie carotid endarterectomy. Both devices are commercially available in Europe and other markets outside the US.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.